Roger Ferreira (He/Him)
About Roger Ferreira (He/Him)
Roger Ferreira is a Team Manager at the European Patent Office, overseeing Team Biological Material B since 2020. He holds a Doctorate in Biochemistry and Molecular Biology from Université Paris-Sud and has extensive experience in patent examination and research.
Work at European Patent Office
Roger Ferreira has been employed at the European Patent Office (EPO) since 2005. He initially served as a Patent Examiner for 11 years, where he evaluated patent applications and contributed to the patent granting process. In 2017, he advanced to the role of Team Manager for Team Coatings & Polysaccharides, overseeing a team focused on specific patent classifications. In 2020, he transitioned to his current position as Team Manager for Team Biological Material B, where he continues to manage operations related to biological materials.
Education and Expertise
Roger Ferreira holds a Doctorate in Biochimie et biologie moléculaire from Université Paris-Sud (Paris XI), which he completed from 1996 to 2001. Prior to this, he earned a Master's degree in the same field from Université de Cergy-Pontoise between 1992 and 1996. His educational background provides him with a strong foundation in biochemistry and molecular biology, which supports his work in patent examination and team management at the EPO.
Background
Before joining the European Patent Office, Roger Ferreira worked as a postdoctoral researcher at LMU - Ludwig-Maximilians-Universität München from 2001 to 2005. This position allowed him to gain valuable research experience in a university setting. His transition to the EPO marked a shift from academic research to the application of scientific knowledge in the field of intellectual property.
Professional Progression
Roger Ferreira's career at the European Patent Office reflects a steady progression through various roles. After starting as a Patent Examiner in 2005, he developed expertise in patent law and examination processes. His promotion to Team Manager in 2017 indicated recognition of his leadership capabilities, which he further demonstrated by managing different teams within the EPO, culminating in his current role overseeing Team Biological Material B since 2020.